- $16.03m
- $14.23m
- $6.04m
- 96
- 44
- 65
- 77
Annual balance sheet for PharmChem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2001 December 31st | 2002 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | PRESS |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.197 | 4.21 | 2.22 | 3.28 | 1.57 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.38 | 3.79 | 0.918 | 0.581 | 0.648 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11.1 | 9.82 | 3.22 | 4.08 | 2.65 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12.9 | 12.1 | 0.001 | 0 | 0 |
Net Goodwill | |||||
Other Long Term Assets | |||||
Total Assets | 28.5 | 22.7 | 3.39 | 4.08 | 2.65 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.3 | 11.5 | 0.542 | 0.447 | 0.567 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.8 | 12.3 | 0.542 | 0.447 | 0.567 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 6.74 | 10.4 | 2.85 | 3.63 | 2.08 |
Total Liabilities & Shareholders' Equity | 28.5 | 22.7 | 3.39 | 4.08 | 2.65 |
Total Common Shares Outstanding |